These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19376317)

  • 1. Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting.
    Cuisset T; Frere C; Quilici J; Gaborit B; Bali L; Poyet R; Faille D; Morange PE; Alessi MC; Bonnet JL
    Am Heart J; 2009 May; 157(5):889-93. PubMed ID: 19376317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical management.
    Cuisset T; Quilici J; Fugon L; Cohen W; Roux P; Gaborit B; Molines L; Fourcade L; Bonnet JL; Carrieri P
    Arch Cardiovasc Dis; 2011 May; 104(5):306-12. PubMed ID: 21693367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.
    Tantry US; Bliden KP; Gurbel PA
    J Am Coll Cardiol; 2005 Nov; 46(9):1705-9. PubMed ID: 16256872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response.
    Cuisset T; Frere C; Quilici J; Morange PE; Camoin L; Bali L; Lambert M; Juhan-Vague I; Alessi MC; Bonnet JL
    Thromb Res; 2009 Feb; 123(4):597-603. PubMed ID: 18499233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.
    Cuisset T; Frere C; Quilici J; Uhry S; Morange PE; Mouret JP; Gaborit B; Bali L; Moro PJ; Lambert M; Bonnet JL
    Thromb Res; 2009 May; 124(1):33-6. PubMed ID: 18990434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aspirin resistance in ED patients with suspected acute coronary syndrome.
    Glauser J; Emerman CL; Bhatt DL; Peacock WF
    Am J Emerg Med; 2010 May; 28(4):440-4. PubMed ID: 20466222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis.
    Ferrari E; Benhamou M; Cerboni P; Marcel B
    J Am Coll Cardiol; 2005 Feb; 45(3):456-9. PubMed ID: 15680728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents and antiplatelet resistance.
    Simon DI; Jozic J
    Am J Cardiol; 2008 Nov; 102(9 Suppl):29J-37J. PubMed ID: 18928790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
    Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
    Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
    Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction.
    Schwartz KA; Schwartz DE; Ghosheh K; Reeves MJ; Barber K; DeFranco A
    Am J Cardiol; 2005 Apr; 95(8):973-5. PubMed ID: 15820166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin resistance after CABG.
    Sanioglu S; Tetik S; Sokullu O; Deniz H; Aydemir N; Yilmaz M; Arslan IY; Bilgen F
    Thorac Cardiovasc Surg; 2009 Aug; 57(5):281-5. PubMed ID: 19629890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
    Pinto Slottow TL; Bonello L; Gavini R; Beauzile P; Sushinsky SJ; Scheinowitz M; Kaneshige K; Xue Z; Torguson R; Tantry U; Pichard AD; Satler LF; Suddath WO; Kent K; Gurbel P; Waksman R
    Am J Cardiol; 2009 Aug; 104(4):525-30. PubMed ID: 19660606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.